as on December 13, 2025 at 2:29 am IST
Day's Low
Day's High
0.47%
Downside
2.07%
Upside
52 Week's Low
52 Week's High
14.34%
Downside
36.38%
Upside
Check Biontech Se market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$23.1B
EPS (TTM)
-3.4154
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.43%
PE Ratio (TTM)
-40.18
Industry PE ratio
19.200384615384614
PEG Ratio
0.0449
EBITDA
-467.8M
Revenue (TTM)
3.2B
Profit Margin
-18.13%
Return On Equity TTM
-3.04%
Track how Biontech Se P/E has moved over time to understand its valuation trends.
Biontech Se in the last 5 years
Lowest (-69.14x)
June 30, 2025
Today (-40.18x)
December 13, 2025
Industry (19.20x)
December 13, 2025
Highest (26.31x)
December 31, 2023
Today’s Price to Earnings Ratio: -40.18x
Compare market cap, revenue, PE, and other key metrics of Biontech Se with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $23.1B | -25.52% | -40.18 | -18.13% | |
| BUY | $42.0B | 393.88% | -16.34 | -264.83% | |
| BUY | $54.5B | 206.63% | 1422.86 | 1.36% | |
| BUY | $114.3B | 101.65% | 31.25 | 31.35% | |
| BUY | $79.2B | 54.51% | 17.42 | 32.13% |
The Biontech Se stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Biontech Se investment value today
Current value as on today
₹85,504
Returns
Returns from Biontech Se Stock
Dollar Returns*
₹6,762 (+6.76%)
Based on 24 analysts
54.17%
Buy
37.50%
Hold
8.33%
Sell
Based on 24 analysts, 54.17% of analysts recommend a 'BUY' rating for Biontech Se. Average target price of $138.62
Get share price movements and forecasts by analysts on Biontech Se.
What analysts predicted
31.62%UPSIDE
Target Price
$138.62
Current Price
$94.79
Analyzed by
24 Analysts
Target
$138.62
Biontech Se target price $138.62, a slight upside of 31.62% compared to current price of $94.79. According to 24 analysts rating.
Search interest for Biontech Se Stock has increased by 74% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:74% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 26 November
Thu, 03:28 AM
-BioNTech's exchange offer for CureVac shares approved, aiming for at least 80% ownership to enhance market position.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -415.8M → -28.7M (in $), with an average increase of 627.3% per quarter
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 182.8M → 1.51B (in $), with an average increase of 56.4% per quarter
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 885.1% return, outperforming this stock by 931.9%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 175.0% return, outperforming this stock by 196.2%
Price Dip
![]()
In the last 1 month, BNTX stock has moved down by -8.7%
| Organisation | Biontech Se |
| Headquarters | An der Goldgrube 12, Mainz, Germany, 55131 |
| Industry | Health Technology |
| CEO | Dr. Ugur Sahin M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Ramon Zapata-Gomez | CFO & Member of Management Board |
Ms. Lisa Birringer | Senior Vice President of Global Financial Reporting & Accounting |
Mr. Douglas Maffei Ph.D. | Vice President of Strategy & Investor Relations |
Ms. Beate Berns | Senior Vice President of Global Human Resources |
Dr. Oliver Henning Ph.D. | Senior Vice President of Operations |
Dr. James Timothy Patrick Ryan Ph.D. | Chief Legal & Business Officer and Member of the Management Board |
Ms. Annemarie Hanekamp | Chief Commercial Officer & Member of Management Board |
Dr. Sierk Poetting Ph.D. | MD, COO & Member of Management Board |
Dr. Ugur Sahin M.D. | Co-Founder, CEO & Chair of the Management Board |
Dr. Ozlem Tureci M.D. | Co-Founder, Chief Medical Officer & Member of Management Board |
Biontech Se share price today is $94.79 as on at the close of the market. Biontech Se share today touched a day high of $96.75 and a low of $94.34.
Biontech Se share touched a 52 week high of $129.27 on and a 52 week low of $81.2 on . Biontech Se stock price today i.e. is closed at $94.79,which is 26.67% down from its 52 week high and 16.74% up from its 52 week low.
Biontech Se market capitalisation is $0.02T as on .
Indian investors can start investing in Biontech Se (BNTX) shares with as little as ₹90.544 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹905.44 in Biontech Se stock (as per the Rupee-Dollar exchange rate as on ).
Based on Biontech Se share’s latest price of $94.79 as on December 13, 2025 at 2:29 am IST, you will get 0.1055 shares of Biontech Se. Learn more about
fractional shares .
Biontech Se stock has given -25.52% share price returns and 21.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?